Identification of an HIV-1 replication inhibitor which rescues host restriction factor APOBEC3G in Vif-APOBEC3G complex

被引:24
|
作者
Zhang, Shaoyang [1 ]
Zhong, Limei [2 ]
Chen, Bing [1 ]
Pan, Ting [1 ]
Zhang, Xue [1 ]
Liang, Liting [1 ]
Li, Qianwen [1 ]
Zhang, Ziying [4 ]
Chen, Hui [1 ]
Zhou, Jie [1 ]
Luo, Haihua [1 ]
Zhang, Hui [1 ,3 ]
Bai, Chuan [1 ,3 ]
机构
[1] Sun Yat Sen Univ, Zhongshan Sch Med, Inst Human Virol, Guangzhou 510080, Guangdong, Peoples R China
[2] Guangdong 2 Prov Peoples Hosp, Clin Lab, Guangzhou 510080, Guangdong, Peoples R China
[3] Sun Yat Sen Univ, Zhongshan Sch Med, Minist Educ, Key Lab Trop Dis Control, Guangzhou 510080, Guangdong, Peoples R China
[4] Guangzhou Molcalx Informat & Technol Ltd, Guangzhou, Guangdong, Peoples R China
基金
中国国家自然科学基金; 高等学校博士学科点专项科研基金;
关键词
HIV-1; Vif; APOBEC3G; Elongin C; ZBMA-1; ANTIRETROVIRAL DRUG-RESISTANCE; IMMUNODEFICIENCY-VIRUS TYPE-1; SMALL-MOLECULE INHIBITION; E3 UBIQUITIN LIGASE; VIF PROTEIN; CYTIDINE DEAMINASE; ANTIVIRAL ACTIVITY; ENZYME APOBEC3G; UNITED-STATES; SOCS-BOX;
D O I
10.1016/j.antiviral.2015.07.009
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
HIV-1 Vif protein is one of the most crucial accessory proteins for viral replication. It efficiently counteracts the important host restriction factor APOBEC3G (apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 3G, A3G) which is lethal to HIV-1 by causing G to A mutation of viral genome. Vif protein mediates degradation of APOBEC3G via the complicated protein-protein interactions of Vif, APOBEC3G, Elongin C/B and Cullin 5. The importance of Vif-APOBEC3G complex makes it a good potential target to develop new therapeutics of HIV-1. We identified a potent HIV-1 replication inhibitor (ZBMA-1, IC50 = 1.01 mu M) that efficiently protected APOBEC3G protein by targeting Vif-APOBEC3G complex. The co-immunoprecipitation and docking studies indicated that compound ZBMA-1 affected the binding of Elongin C with Vif protein. (C) 2015 Elsevier B.V. All rights reserved.
引用
收藏
页码:20 / 27
页数:8
相关论文
共 50 条
  • [21] Reassessing APOBEC3G Inhibition by HIV-1 Vif-Derived Peptides
    Richards, Christopher M.
    Li, Ming
    Perkins, Angela L.
    Rathore, Anurag
    Harki, Daniel A.
    Harris, Reuben S.
    JOURNAL OF MOLECULAR BIOLOGY, 2017, 429 (01) : 88 - 96
  • [22] Variability in HIV-1 transmitted/founder virus susceptibility to combined APOBEC3F and APOBEC3G host restriction
    Gaba, Amit
    Yousefi, Maria
    Bhattacharjee, Shreoshri
    Chelico, Linda
    JOURNAL OF VIROLOGY, 2025, 99 (01)
  • [23] APOBEC3G Impairs the Multimerization of the HIV-1 Vif Protein in Living Cells
    Batisse, Julien
    Guerrero, Santiago Xavier
    Bernacchi, Serena
    Richert, Ludovic
    Godet, Julien
    Goldschmidt, Valerie
    Mely, Yves
    Marquet, Roland
    de Rocquigny, Hugues
    Paillart, Jean-Christophe
    JOURNAL OF VIROLOGY, 2013, 87 (11) : 6492 - 6506
  • [24] The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif
    Ann M Sheehy
    Nathan C Gaddis
    Michael H Malim
    Nature Medicine, 2003, 9 : 1404 - 1407
  • [25] HIV-1 Vif binds to APOBEC3G mRNA and inhibits its translation
    Mercenne, Gaelle
    Bernacchi, Serena
    Richer, Delphine
    Bec, Guillaume
    Henriet, Simon
    Paillart, Jean-Christophe
    Marquet, Roland
    NUCLEIC ACIDS RESEARCH, 2010, 38 (02) : 633 - 646
  • [26] HIV-1 Vif binds to APOBEC3G mRNA and regulates its translation
    Marquet, R.
    Mercenne, G.
    Bernacchi, S.
    Richer, D.
    Bec, G.
    Henriet, S.
    Paillart, J. -C
    CENTENNIAL RETROVIRUS MEETING, 2010, : 27 - 30
  • [27] Degradation-Independent Inhibition of APOBEC3G by the HIV-1 Vif Protein
    Stupfler, Benjamin
    Verriez, Cedric
    Gallois-Montbrun, Sarah
    Marquet, Roland
    Paillart, Jean-Christophe
    VIRUSES-BASEL, 2021, 13 (04):
  • [28] The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif
    Sheehy, AM
    Gaddis, NC
    Malim, MH
    NATURE MEDICINE, 2003, 9 (11) : 1404 - 1407
  • [29] Structural insights into RNA bridging between HIV-1 Vif and antiviral factor APOBEC3G
    Kouno, Takahide
    Shibata, Satoshi
    Shigematsu, Megumi
    Hyun, Jaekyung
    Kim, Tae Gyun
    Matsuo, Hiroshi
    Wolf, Matthias
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [30] APOBEC3G and HIV-1: Strike and counterstrike
    Soros V.B.
    Greene W.C.
    Current Infectious Disease Reports, 2006, 8 (4) : 317 - 323